Results 261 to 270 of about 368,340 (301)

Hepatitis B and End-Stage Liver Disease

Clinics in Liver Disease, 2007
Hepatitis B virus (HBV) is the most common cause of chronic hepatitis and end-stage liver disease worldwide. Untreated, chronic hepatitis B acquired early in life results in cirrhosis, liver failure, or hepatocellular carcinoma in up to 40% of individuals.
Ilan S, Weisberg, Robert S, Brown, Samuel H, Sigal   +2 more
openaire   +2 more sources

The treatment of end‐stage liver disease in childhood

Journal of Paediatrics and Child Health, 1988
With the availability of orthotopic liver transplantation as a definitive treatment option for most cases of end-stage liver disease in children, there is renewed interest in this hitherto universally fatal condition. The potential for long-term survival after liver transplantation without disability is a realistic prospect for the majority, although ...
openaire   +4 more sources

Nutrition in pediatric end-stage liver disease

Current Opinion in Clinical Nutrition & Metabolic Care
Purpose of review The aim of this review is to outline recent studies relating to nutritional status and outcomes in pediatric end-stage liver disease. Main findings Pediatric patients with chronic and end-stage liver disease are at high risk of malnutrition. Given additional growth
Tejas S, Desai, Jessie M, Hulst, Robert, Bandsma, Sagar, Mehta   +3 more
openaire   +2 more sources

Hemostatic Defects in End Stage Liver Disease

Critical Care Clinics, 2005
End stage liver disease results in a complex and variably severe failure of hemostasis that predisposes to abnormal bleeding. The diverse spectrum of hemostatic defects includes impaired synthesis of clotting factors, excessive fibrinolysis, disseminated intravascular coagulation, thrombocytopenia, and platelet dysfunction.
openaire   +2 more sources

Liver transplantation in the era of model for end‐stage liver disease

Liver International, 2004
Abstract: Liver transplantation is challenged by organ shortage and prolonged waiting list time. The goal of the ideal organ allocation system is to transplant individuals least likely to survive without a liver transplantation, and maintain appropriate rates of postoperative survival.
Victor S, Wang, Sammy, Saab
openaire   +2 more sources

The case for liver transplantation in end‐stage alcoholic liver disease

Drug and Alcohol Review, 1996
AbstractLiver transplantation is now a routine procedure and is seen as a valid treatment option for end‐stage liver disease. Alcoholism has been regarded as a relative or absolute contraindication to liver transplantation in many transplant units. Recent data document a success rate for transplantation in alcoholic patients that equals that in other ...
openaire   +2 more sources

The Patient with End-Stage Liver Disease

2017
Cirrhosis, the end-stage of liver diseases, is an increasing cause of morbidity and mortality [1]. The decompensation of the liver function is a key event during the natural history of this disease as it substantially worsen patient prognosis. Surgery and anesthesia are well-known cause of cirrhosis decompensation that may lead, at worst, to “acute on ...
Emmanuel Weiss, Catherine Paugam-Burtz
openaire   +1 more source

MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era

Gastroenterology, 2021
Ajitha Mannalithara, Julie K Heimbach, Patrick S Kamath   +2 more
exaly  

Physical and Mental Quality of Life in Patients With End-Stage Liver Disease and Their Informal Caregivers

Clinical Gastroenterology and Hepatology, 2021
Lissi Hansen, , Evan J Firsick
exaly  

Nutritional considerations in end‐stage liver disease

Journal of Gastroenterology and Hepatology, 2011
Simone I, Strasser, Helen, Vidot
openaire   +2 more sources